Factor XIII Val34Leu polymorphism does not affect the risk for thrombotic complications in patients with antiphospholipid syndrome.
dc.contributor.author | Hancer, VS | |
dc.contributor.author | Inanc, Murat | |
dc.contributor.author | Nalcaci, M | |
dc.contributor.author | Pekcelen, Y | |
dc.contributor.author | Diz-Kucukkaya, R | |
dc.date.accessioned | 2021-03-05T11:05:36Z | |
dc.date.available | 2021-03-05T11:05:36Z | |
dc.identifier.citation | Diz-Kucukkaya R., Hancer V., Inanc M., Nalcaci M., Pekcelen Y., "Factor XIII Val34Leu polymorphism does not affect the risk for thrombotic complications in patients with antiphospholipid syndrome.", 45th Annual Meeting of the American-Society-of-Hematology, SAN DIEGO, CALIFORNIA, 6 - 09 Aralık 2003, cilt.102 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_a6726fe3-c6aa-437d-873b-9c854765b1c4 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/111310 | |
dc.language.iso | eng | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | İç Hastalıkları | |
dc.subject | Hematoloji | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Tıp | |
dc.subject | Klinik Tıp | |
dc.subject | HEMATOLOJİ | |
dc.title | Factor XIII Val34Leu polymorphism does not affect the risk for thrombotic complications in patients with antiphospholipid syndrome. | |
dc.type | Bildiri | |
dc.contributor.department | , , | |
dc.identifier.volume | 102 | |
dc.contributor.firstauthorID | 129210 |
Files in this item
Files | Size | Format | View |
---|---|---|---|
There are no files associated with this item. |
This item appears in the following Collection(s)
-
Bildiri [64839]